Appetite Suppression - Cargi 5mg
$40.00
Out of stock
Cagrilintide is a long-acting amylin analog that targets brain satiety centers to significantly suppress appetite, slow gastric emptying, and promote sustained fullness. As a monotherapy, it has achieved over 11% weight loss in trials, and when combined with GLP-1 medications, it can trigger weight reductions exceeding 20%
Core Benefits
Significant Weight Loss: Clinical trials (such as the REDEFINE 1 study) show that cagrilintide promotes consistent weight loss. When used alone, patients lost an average of nearly 12% of their body weight over 68 weeks.
Powerful Appetite Suppression: Unlike GLP-1s, cagrilintide acts on amylin and calcitonin receptors in the brainstem to target emotional hunger and reward-driven cravings.
Enhanced Satiety & Digestion: It slows down gastric emptying, keeping food in the stomach longer so you feel satisfied with smaller portions.
Blood Sugar Management: By suppressing glucagon secretion and smoothing digestion, it naturally flattens post-meal blood sugar spikes—a major benefit for individuals with insulin resistance or prediabetes.
Combination Synergy: When paired with GLP-1s (like semaglutide), the combination creates a dual-action effect that can rival the weight loss seen in aggressive procedures like bariatric surgery.
*For Research Purposes Only